Literature DB >> 2596511

Three additional cases of the congenital hypothalamic "hamartoblastoma" (Pallister-Hall) syndrome.

P D Pallister1, F Hecht, J Herrman.   

Abstract

The cause of this syndrome remains unknown. Epidemiologic studies should be done by experts. The first two cases above gave a "muddy" history for possible teratogens--a "recall bias"--one of a vaginal foam spermicide, one of exposure over several days to a heavy residue of aviation diesel fuel exhaust. We do not think these are pertinent but they do point to the problem of getting a meaningful history. In addressing this problem (in a letter of 5/27/82) R.J. Berry, M.D., medical epidemiologist, Centers for Disease Control, Atlanta, Georgia, wrote "... a designed study providing standardized interview forms with controls could be designed if cases continue to appear." Since this seems to be the case, perhaps this approach should be embraced. A teratogen(s) appears to be a good bet since the condition was recognized suddenly with the first Montana case in February, 1978. Even though no record has been found in the files of the Armed Forces Institute of Pathology, Children's Hospital Automated Medical Programs (CHAMP), Montreal or Wisconsin and one or two other places, it might be worthwhile to look back at all cases of imperforate anus which have come to autopsy for possible associated CNS lesions. We may be deluding ourselves in considering the condition as "new." Chromosomes were usually studied in lymphocytes, once on the tumor and once or twice on marrow. It might be well to do more than one tissue in all new cases. Once again there appears to be no "obligatory" finding for any one syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2596511     DOI: 10.1002/ajmg.1320330417

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  Lineage-specific roles of hedgehog-GLI signaling during mammalian kidney development.

Authors:  Robert D'Cruz; Katryna Stronks; Christopher J Rowan; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2019-03-28       Impact factor: 3.714

2.  Recurrence of Pallister-Hall syndrome in two sibs.

Authors:  H M Thomas; P J Todd; D Heaf; A E Fryer
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

Review 3.  Control of mammalian kidney development by the Hedgehog signaling pathway.

Authors:  Jason E Cain; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2010-12-15       Impact factor: 3.714

Review 4.  Mammalian kidney development: principles, progress, and projections.

Authors:  Melissa H Little; Andrew P McMahon
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-05-01       Impact factor: 10.005

5.  GLI3 repressor controls functional development of the mouse ureter.

Authors:  Jason E Cain; Epshita Islam; Fiona Haxho; Joshua Blake; Norman D Rosenblum
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

6.  Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease.

Authors:  Xiaofang Wang; Li Jiang; Ka Thao; Caroline R Sussman; Timothy LaBranche; Michael Palmer; Peter C Harris; G Stanley McKnight; Klaus P Hoeflich; Stefanie Schalm; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 14.978

Review 7.  Lower urinary tract development and disease.

Authors:  Hila Milo Rasouly; Weining Lu
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-02-13

Review 8.  Holoprosencephaly-polydactyly ('pseudotrisomy 13') syndrome: a syndrome with features of hydrolethalus and Smith-Lemli-Opitz syndromes. A collaborative multicentre study.

Authors:  A Verloes; S Aymé; D Gambarelli; M Gonzales; M Le Merrer; N Mulliez; N Philip; J Roume
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

9.  Urogenital development in Pallister-Hall syndrome is disrupted in a cell-lineage-specific manner by constitutive expression of GLI3 repressor.

Authors:  Joshua Blake; Di Hu; Jason E Cain; Norman D Rosenblum
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.